Neuren Pharmaceuticals’ (ASX:NEU) Chief Executive Officer, Jon Pilcher, sits down with Senior Analyst Scott Power. In this piece, Jon outlines a number of upcoming value drivers for the company.

Under the microscope: Covid-19 Vaccine - Dr. Derek Jellinek, Senior Analyst

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.